Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasm Metastasis × NVP-BKM120 × Clear all

Phase

Status

Completed 8 Terminated 5 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1

Interventions

Fluorouracil 18 Oxaliplatin 15 Capecitabine 15 Leucovorin 13 Irinotecan 11 Gemcitabine 11 Drug Therapy 11 Cetuximab 10 Radiosurgery 9 Cisplatin 9 Bevacizumab 9 Docetaxel 8 Radiotherapy 6 Paclitaxel 6 Neoadjuvant Therapy 6 Everolimus 6 spartalizumab 5 pembrolizumab 5 Trastuzumab 5 Sunitinib 5 S 1 (combination) 5 Cyclophosphamide 5 Chemotherapy, Adjuvant 5 Carboplatin 5 manganese chloride 4 Surgical Procedures, Operative 4 Sorafenib 4 Nivolumab 4 Immunotherapy 4 Immune Checkpoint Inhibitors 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02452294 2017-05-03

BUMPER

University Hospital Tuebingen

Phase 2 Unknown

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡